Loading...
Response to neoadjuvant chemotherapy in ICON8: a GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment
Clamp, Andrew R McNeish, I Dean, A Gallardo-Rincon, D Kim, J O'Donnell, D Hook, J Blagden, S Brenton, J Naik, R
Clamp, Andrew R
McNeish, I
Dean, A
Gallardo-Rincon, D
Kim, J
O'Donnell, D
Hook, J
Blagden, S
Brenton, J
Naik, R
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 93.92 KB
Keywords
Type
Meetings and Proceedings
Citation
Clamp AR, McNeish IA, Dean A, Gallardo-Rincon D, Kim JW, O�Donnell DM, et al. 943PD Response to neoadjuvant chemotherapy in ICON8: a GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment. Ann Oncol. 2018;29(suppl_8):336.